VIMTA LABS
|
VIMTA LABS Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 30.02 | 22.02 | 21.37 | 18.57 | 9.62 |
| CEPS(Rs) | 45.89 | 36.97 | 35.17 | 29.04 | 19.99 |
| DPS(Rs) | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Book NAV/Share(Rs) | 167.37 | 138.66 | 123.92 | 104.37 | 87.89 |
| Tax Rate(%) | 24.99 | 21.91 | 25.90 | 25.82 | 25.13 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 35.45 | 32.59 | 29.69 | 28.90 | 25.20 |
| EBIT Margin(%) | 26.43 | 22.39 | 21.10 | 20.60 | 14.62 |
| Pre Tax Margin(%) | 25.87 | 21.66 | 20.26 | 20.06 | 13.58 |
| PAT Margin (%) | 19.41 | 16.91 | 15.01 | 14.88 | 10.17 |
| Cash Profit Margin (%) | 29.67 | 28.40 | 24.70 | 23.27 | 21.14 |
| Performance Ratios | |||||
| ROA(%) | 15.76 | 13.14 | 14.33 | 14.25 | 8.24 |
| ROE(%) | 19.65 | 16.78 | 18.73 | 19.32 | 11.58 |
| ROCE(%) | 25.23 | 20.55 | 24.25 | 23.85 | 14.24 |
| Asset Turnover(x) | 0.81 | 0.78 | 0.95 | 0.96 | 0.81 |
| Sales/Fixed Asset(x) | 0.91 | 0.91 | 1.11 | 1.14 | 1.01 |
| Working Capital/Sales(x) | 2.79 | 2.79 | 2.97 | 3.57 | 3.62 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.10 | 1.09 | 0.90 | 0.87 | 0.99 |
| Receivable days | 102.52 | 105.54 | 90.82 | 99.27 | 114.25 |
| Inventory Days | 26.39 | 29.92 | 23.16 | 21.17 | 27.73 |
| Payable days | - | - | - | - | 1,516.57 |
| Valuation Parameters | |||||
| PER(x) | 33.31 | 20.19 | 14.70 | 16.97 | 16.74 |
| PCE(x) | 21.79 | 12.03 | 8.93 | 10.85 | 8.05 |
| Price/Book(x) | 5.98 | 3.21 | 2.54 | 3.02 | 1.83 |
| Yield(%) | 0.20 | 0.45 | 0.64 | 0.63 | 1.24 |
| EV/Net Sales(x) | 6.39 | 3.39 | 2.13 | 2.55 | 1.81 |
| EV/Core EBITDA(x) | 17.43 | 10.02 | 6.92 | 8.67 | 7.08 |
| EV/EBIT(x) | 24.19 | 15.15 | 10.10 | 12.39 | 12.40 |
| EV/CE(x) | 5.68 | 2.94 | 2.27 | 2.32 | 1.39 |
| M Cap / Sales | 6.46 | 3.42 | 2.21 | 2.52 | 1.70 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 19.19 | -8.42 | 14.18 | 32.02 | 15.71 |
| Core EBITDA Growth(%) | 29.09 | 0.76 | 19.44 | 51.82 | 61.96 |
| EBIT Growth(%) | 40.70 | -2.81 | 16.94 | 85.98 | 152.37 |
| PAT Growth(%) | 36.76 | 3.20 | 15.20 | 93.12 | 206.91 |
| EPS Growth(%) | 36.36 | 3.01 | 15.10 | 93.12 | 206.92 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.02 | 0.06 | 0.05 | 0.08 | 0.15 |
| Current Ratio(x) | 2.92 | 2.91 | 2.87 | 2.64 | 2.09 |
| Quick Ratio(x) | 2.53 | 2.46 | 2.47 | 2.27 | 1.82 |
| Interest Cover(x) | 47.84 | 30.75 | 25.14 | 38.00 | 14.10 |
| Total Debt/Mcap(x) | - | 0.02 | 0.02 | 0.03 | 0.08 |
Compare Financial Ratios of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹2,018.2 Cr | 1.6% | -5.6% | -13.7% | Stock Analytics | |
| SAGILITY | ₹19,310.5 Cr | -0.5% | -0.9% | -10.4% | Stock Analytics | |
| PRIME FOCUS | ₹18,786.7 Cr | 2.8% | -27.2% | 160.4% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹18,639.4 Cr | -1% | 5.9% | -26.8% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹16,113.1 Cr | 18.9% | 2.9% | -2.5% | Stock Analytics | |
| INDEGENE | ₹12,239.0 Cr | -0.5% | 1.9% | -15.2% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | 1.6% |
-5.6% |
-13.7% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses